NC-6004(Nanoplatin) and Gemcitabine to Treat Pancreatic Cancer in Asia

Clinical trial NCT00910741 · COMPLETED

Trial details

NCT number: NCT00910741
Sponsor: NanoCarrier Co., Ltd.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Locally Advanced and Metastatic Pancreatic Cancer

Start date: 2009-05-01
Primary completion: 2013-07-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.